Authors: ROLLEMA H CLARKE T SPROUSE JS SCHULZ DW

Citation: H. Rollema et al., COMBINED ADMINISTRATION OF A 5-HYDROXYTRYPTAMINE (5-HT)(1D) ANTAGONIST AND A 5-HT REUPTAKE INHIBITOR SYNERGISTICALLY INCREASES 5-HT RELEASEIN GUINEA-PIG HYPOTHALAMUS IN-VIVO, Journal of neurochemistry, 67(5), 1996, pp. 2204-2207

Authors: SPROUSE JS WILKINSON LO

Citation: Js. Sprouse et Lo. Wilkinson, INNOVATIVE THERAPEUTIC ACTIONS BY TARGETING SEROTONIN 1A RECEPTORS SELECTIVELY, International review of psychiatry, 7(1), 1995, pp. 5-15

Authors: IYER RN SPROUSE JS AGHAJANIAN GK ROTH RH BRADBERRY CW

Citation: Rn. Iyer et al., TRYPTOPHAN PRETREATMENT AUGMENTATION OF P-CHLOROAMPHETAMINE-INDUCED SEROTONIN AND DOPAMINE RELEASE AND REDUCTION OF LONG-TERM NEUROTOXICITY, Biochemical pharmacology, 48(7), 1994, pp. 1501-1508

Authors: SPROUSE JS MCCARTY DR DUDLEY MW

Citation: Js. Sprouse et al., APPARENT REGIONAL DIFFERENCES IN 5-HT(1A) BINDING MAY REFLECT [H-3] 8-OH-DPAT LABELING OF SEROTONIN UPTAKE SITES, Brain research, 617(1), 1993, pp. 159-162